Sienna Biopharmaceuticals, Inc.
SNNAQ
$0.00
$0.000.00%
OTC PK
| 09/30/2019 | 06/30/2019 | 03/31/2019 | 12/31/2018 | 09/30/2018 | |
|---|---|---|---|---|---|
| Net Income | -3.97M | -8.26M | -16.38M | -19.34M | -16.79M |
| Total Depreciation and Amortization | 36.00K | 37.00K | 39.00K | 40.00K | 39.00K |
| Total Amortization of Deferred Charges | 526.00K | 237.00K | 233.00K | 129.00K | 130.00K |
| Total Other Non-Cash Items | -6.16M | 786.00K | 6.36M | 5.47M | 935.00K |
| Change in Net Operating Assets | -8.28M | -1.21M | -3.02M | -1.90M | -199.00K |
| Cash from Operations | -17.84M | -8.42M | -12.77M | -15.60M | -15.89M |
| Capital Expenditure | 0.00 | 0.00 | -4.00K | -6.00K | -16.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | 0.00 | -4.00K | -6.00K | -16.00K |
| Total Debt Issued | -- | -- | -- | 13.00K | -44.00K |
| Total Debt Repaid | -20.00M | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 452.00K | 21.44M | 262.00K | 5.04M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -16.00K | 18.00K | -- |
| Cash from Financing | -20.00M | 452.00K | 21.43M | 293.00K | 4.99M |
| Foreign Exchange rate Adjustments | 1.00K | 3.00K | -10.00K | -137.00K | 0.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -37.84M | -7.96M | 8.64M | -15.45M | -10.91M |